# Transversus Abdominis Plane (TAP) Block for Cesarean Section

> **NCT01015807** · NA · COMPLETED · sponsor: **University of Washington** · enrollment: 90 (actual)

## Conditions studied

- Hyperalgesia, Secondary

## Interventions

- **DRUG:** Bupivacaine Placebo
- **DRUG:** Clonidine Placebo
- **DRUG:** Bupivacaine
- **DRUG:** Clonidine

## Key facts

- **NCT ID:** NCT01015807
- **Lead sponsor:** University of Washington
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-11
- **Primary completion:** 2010-08
- **Final completion:** 2012-08
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2017-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01015807

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01015807, "Transversus Abdominis Plane (TAP) Block for Cesarean Section". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01015807. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*